CECELIA VIRGIL: Open Payments
NPI 1063489334 · BOCA RATON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$700 in 22 payments from 14 companies in 2025. Trend: 2023 $630 · 2024 $692 · 2025 $700
Food & beverage: $700
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $164 |
| Medtronic, Inc. | 1 | $113 |
| Incyte Corporation | 3 | $88 |
| Exelixis Inc. | 3 | $59 |
| PFIZER INC. | 2 | $54 |
| Merck Sharp & Dohme LLC | 2 | $39 |
| Genentech USA, Inc. | 1 | $32 |
| Alexion Pharmaceuticals, Inc. | 1 | $30 |
| GlaxoSmithKline, LLC. | 1 | $25 |
| Daiichi Sankyo Inc. | 1 | $21 |
Products named: RYBREVANT, VENASEAL, JAKAFI, CABOMETYX, KEYTRUDA, Tecentriq, ULTOMIRIS, TIVDAK.
Industry payments across FL — which companies pay providers there.
